您要查找的是不是：
- Laennec liver cirrhosis 拉埃内克肝硬变(萎缩性门脉性肝硬变)
- It and liver cirrhosis have again different. 它和肝硬化又有不同。
- Analysis prognosis of Plasma Sodium Level in the Liver Cirrhosis. 血钠水平对肝硬化病人预后的影响。
- What distinction do chronic hepatitis and liver cirrhosis have? 慢性肝炎与肝硬化有什么区别?
- Is liver cirrhosis inchoate can you appear what apparent symptom? 肝硬化早期会出现哪些明显症状?
- Liver cirrhosis and diabetes mellitus at 5 years had a 57% survival rate. 肝硬化和糖尿病5年的成活率是57%25.
- Method Liver cirrhosis model rats were made by carbon tetrachloride(CCl_4). 方法采用四氯化碳(CCL_4)建立肝硬化模型,同时设立正常对照组,以橄榄油处理。
- Why " is strong liver soft firm soup " can you treat liver cirrhosis? 为什么“强肝软坚汤”能治疗肝硬化?
- The liver cirrhosis model was established in Wistar rats with CCl_4 injection. 本文采用60%25四氯化碳（CCl4）皮下注射复制大鼠肝硬变模型。
- In patients with liver cirrhosis hematemesis occurred at home how to do? 肝硬化患者在家中发生呕血怎么办？
- Objective To find out the change of the renal hemodynamics in liver cirrhosis. 目的研究肝硬化患者肾脏血液动力学的改变。
- The investigative team enrolled 56 patients with liver cirrhosis in a prospective cohort study. 试验小组纳取了56名患有英硬化的患者进行了列队性研究.
- The cumulative survival rates of patients with liver cirrhosis and normal glucose tolerance were95% at5 years. 糖尿病在21名患者中发现;被削弱的葡萄糖耐受有13名;正常的葡萄糖耐受22名.
- Objective: To study the histopathological changes of the brain and its mechanism in liver cirrhosis model of rats. 目的:探讨肝硬化时脑组织形态改变及其发生机制。
- Serum lipids were measured in the patients with hepatoma, liver cirrhosis and controls. 我们对肝细胞瘤、肝硬化以及对照人员作了血脂测定。
- Aim and Method: The serum parathyroid (PTH), calcitomin (CT), calcium and phosphatase were detected in rats with liver cirrhosis. 目的和方法:采用放免方法测定肝硬化大鼠血甲状旁腺素(PTH)、降钙素(CT)及血钙、磷水平与肝性骨营养不良的关系。
- There are also some patients with liver cirrhosis showed a number of complications, such as melena, hematemesis. 也有部分患者表现为肝硬化的一些并发症，如黑便、呕血。
- The cumulative survival rates of patients with liver cirrhosis and normal glucose tolerance were 95% at 5 years. 累计的5年成活率在正常葡萄糖耐受感应花环者中为95%25.
- Liver cirrhosis was induced by oral administration of thioacetamide (TAA) solution(35mg/dl) for experimental group. 以硫代乙酰胺(thioacetamide，TAA)诱导大鼠肝纤维化/肝硬化模型作为实验组。
- Following the liver cirrhosis degree progress,the abnormal rate of AST/ALT ratio tended to ascend(?P?<0 05). (2 )不同级别肝硬化患者AST/ALT比值异常率之间的线性趋势有显著性意义 (P <0 0 5 ) ;
